Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours
Abstract
Importance: Whether intravenous tenecteplase prior to endovascular treatment (EVT) for ischemic stroke reduces disability in the late time window is unclear. Objective: To investigate the adverse events and efficacy of tenecteplase prior to EVT in patients 4.5 to 24 hours after ischemic stroke onset due to proximal middle cerebral artery (MCA) occlusion. Design, Setting, and Participants: Multicenter, phase 3, randomized, open-label, blinded end point, superiority trial conducted at 40 centers in China. Adult (≥18 years) patients with acute ischemic stroke 4.5 to 24 hours after last known to be well due to MCA-M1 or proximal M2 occlusion with salvageable brain tissue (ischemic core volume
Fields of Study & Subjects
Acute Ischemic Stroke Management
Stroke Rehabilitation and Recovery
Intracerebral and Subarachnoid Hemorrhage Research
Publication details
- Journal / source
- JAMA
- Publisher
- American Medical Association (AMA)
- Volume
- 335
- Issue
- 21
- Pages
- 1849–1849
- Publication date
- 8 May 2026
- Language
- EN